SCHEMBL25538852

SCHEMBL25538852

CC1(C)c2cc(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccc6c(c5)sc5ccccc56)n4)c4ccccc34)ccc2-c2cc3ccccc3cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.33
HPGD P15428 5/20 0.33
MAPT P10636 5/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
ACACA Q13085 1/20 0.33
MEN1 O00255 6/20 0.33
KMT2A Q03164 6/20 0.33
KDM4E B2RXH2 3/20 0.32
LMNA P02545 2/20 0.32
GLA P06280 1/20 0.32
CTRC Q99895 1/20 0.32
TSHR P16473 2/20 0.31
ATM Q13315 2/20 0.31
USP2 O75604 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539386 0.96 CYP1A1 (0.32) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL25538856 0.94 CYP1A1 (0.33) ALDH1A1HPGDMAPTCYP1A1CYP1B1
SCHEMBL25536395 0.93 ALDH1A1 (0.34) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL25533725 0.92 F9 (0.34) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL25539388 0.90 CYP1A1 (0.32) ALDH1A1HPGDMAPTCYP1A1CYP1B1
SCHEMBL25539745 0.90 ALDH1A1 (0.33) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL25536928 0.89 ALDH1A1 (0.33) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL25533997 0.89 ALDH1A1 (0.33) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL25538783 0.88 MEN1 (0.41) ALDH1A1HPGDMAPTSMN1; SMN2CYP1A1
SCHEMBL25538788 0.87 MEN1 (0.40) ALDH1A1HPGDMAPTSMN1; SMN2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ALDH1A1 254/4885HPGD 3854/4885MAPT 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.